Facilities

Our company values of innovation and excellence are reflected in our headquarters and state-of-the-art facilities in a repurposed Victorian waterworks building on the River Thames in Hampton, UK.

Our Location

Innovating internationally

Touchlight is an international biotechnology company with GMP manufacturing facilities, in Hampton, UK.

Hampton, UK

At our Hampton site, we manufacture Research, Toxicology and GMP-grade dbDNA™ as a critical starting material or Active Pharmaceutical Ingredient for Genetic Medicines. We are in the process of expanding our London-based manufacturing facilities to more than triple our manufacturing capacity, allowing us to deliver up to 1 kilogram of GMP dbDNA™ per month. (See details below.)

Facility overview

4 GMP suites, expanding to 15
Quality system established, based on EU GMP Part II (in alignment with ICH Q7)
Facility performs and is monitored to Grade C (ISO7 / Class 10,000) and is validated as Grade D (ISO8 / Class 100,000) in accordance with ISO 14644-1 and US FED 209D
The new product processing facility will be validated, operated and monitored as Grade C (ISO7 / Class 10,000) with Grade B (ISO6 / Class 1,000) validated, operated and monitored bulk filling rooms. All room classifications in accordance with ISO 14644-1 and US FED 209D.

Services

Research grade DNA
Clinical grade DNA
Development services
Regulatory services

Take a tour of our state-of-the-art facilities. Explore our manufacturing facilities, housing the equipment and resources that power our groundbreaking dbDNA™ platform, and see the R&D laboratories and personnel fuelling our technological and applications pipeline solutions.

Large capacity, small footprint

We are in the process of expanding our London-based manufacturing facilities to more than triple our manufacturing capacity, allowing us to deliver up to 1 kilogram of GMP dbDNA™ per month.

Despite this huge capacity, which will enable us to deliver GMP dbDNA™ on a truly global scale, the small footprint of our benchtop equipment means the total facility footprint will be just 7,500 sq ft. This is a fraction of the space required by conventional bioreactor-based plasmid DNA manufacture.